State Street SPDR S&P Biotech ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 127.46
成立日期: 31/01/2006
 
分析
市值分佈:
65.29%
大市值
29.87%
中市值
7.17%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:54) 總持有投資項目: 145  
0%
 
100%
     10大 (16.71%)
代號 名稱 佔比% 持有日期
DYNDyne Therapeutics0.7627/02/2026
APLSApellis Pharmaceuticals0.7527/02/2026
CPRXCatalyst Pharmaceuticals0.7527/02/2026
RXRXRecursion Pharmaceuticals0.7427/02/2026
SNDXSyndax Pharmaceuticals0.7427/02/2026
VERAVera Therapeutics0.7327/02/2026
CLDXCelldex Therapeutics0.7227/02/2026
APGEApogee Therapeutics0.7127/02/2026
NVAXNovavax0.7027/02/2026
BCRXBioCryst Pharmaceuticals0.7027/02/2026
STOKStoke Therapeutics0.6927/02/2026
SRPTSarepta Therapeutics0.6927/02/2026
GRALGRAIL Inc.0.6827/02/2026
AGIOAgios Pharmaceuticals0.6827/02/2026
DNTHDianthus Therapeutics0.6727/02/2026
VCYTVeracyte0.6627/02/2026
NTLAIntellia Therapeutics0.6227/02/2026
VRDNViridian Therapeutics0.6127/02/2026
IOVAIovance Biotherapeutics0.5727/02/2026
VCELVericel Corp0.5627/02/2026
  1    2    3   4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.